575 MADISON AVENUE, NEW YORK, NY
Announces $100.0 Million Private Placement
LB Pharmaceuticals Inc Enters Lease Amendment for Expansion Premises
Appoints Kaya Pai Panandiker as Chief Commercial Officer
Reports 3Q 2025 Financial Results and Recent Corporate Updates
News, Articles of Incorporation
Q3
Prospectus filed pursuant to Rule 424(b)(4)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration of Securities
Amended Registration Statement for Securities
S-1
No filings found
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
S-1MEF